1.
|
Phase: Phase IV Type: Prevention, Treatment Status: Active Age: 30 and over Sponsor: Other Protocol IDs: 940110, NCT00155389
|
|
2.
|
Phase: No phase specified Type: Prevention Status: Active Age: 18 to 90 Sponsor: Pharmaceutical / Industry Protocol IDs: lmrx01, NCT00306280
|
|
3.
|
Phase: No phase specified Type: Prevention Status: Active Age: 19 to 69 Sponsor: Other Protocol IDs: sihp20076, NCT00596401
|
|
4.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: IMI2010-1, 1000-05-310123, NCT01137942
|
|
5.
|
Phase: No phase specified Type: Behavioral study, Prevention Status: Approved-not yet active Age: 3 and under Sponsor: Other Protocol IDs: Krebshilfe-107539, DM8-IESO02, NCT00647413
|
|
6.
|
Phase: No phase specified Type: Prevention, Treatment Status: Approved-not yet active Age: 20 to 70 Sponsor: Other Protocol IDs: 4-2012-0889, NCT01813994
|